Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for freeRegeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.{}

Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.https://www.cnbc.com/2026/04/23/regeneron-inks-drug-pricing-deal-with-trump-will-offer-hearing-loss-therapy-for-free.html